- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Newly FDA-Cleared AI Software Facilitates Advanced Denoising and Accelerated Scan Times for MRI
Enabling up to 80 percent faster MRI scan times, the SubtleHD software is included in the newly launched AI software suite Subtle-Elite.
The Food and Drug Administration (FDA) has granted 510(k) clearance for SubtleHD™, an artificial intelligence (AI) software that reportedly decreases magnetic resonance imaging (MRI) scan times by up to 80 percent for certain sequences.
The SubtleHD software also offers advanced denoising that one can apply for MRI assessment of any body region, according to Subtle Medical, the manufacturer of SubtleHD.
SubtleHD™, an artificial intelligence (AI) software that reportedly enables significant reduction in magnetic resonance imaging (MRI) scan times, has garnered 510(k) clearance from the Food and Drug Administration (FDA). (Images courtesy of Subtle Medical.)
The company is including SubtleHD in a new Subtle-Elite AI software suite that also includes the previously FDA-cleared SubtleSynth, which utilizes deep learning to provide synthetic short tau inversion recovery (STIR) images from T1 and T2-weighted MRI, and SubtleAlign, which provides optimal anatomical alignment for brain MRI scans.
"The FDA clearance of Subtle-HD™ marks a significant milestone in AI-driven radiology, giving hospitals and imaging centers a powerful solution to increase efficiency, improve image quality, and optimize workflows — all without additional hardware costs," noted Ajit Shankaranarayanan, Ph.D., the chief product officer at Subtle Medical. "By combining SubtleHD, SubtleSYNTH, and SubtleALIGN into a single, comprehensive package, Subtle-ELITE™ is setting a new benchmark for the future of MRI."
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
